Long‐term follow‐up of myelodysplastic syndrome patients with moderate/severe anaemia receiving human recombinant erythropoietin + 13‐<i>cis</i>‐retinoic acid and dihydroxylated vitamin <scp>D</scp>3: independent positive impact of erythroid response on survival
Elena Crisà(Candiolo Cancer Institute), Dario Ferrero(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Cristina Foli(JNC (Japan)), Roberto Passera(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Kimberly Blaine Garvey(Ospedali Riuniti di Ancona), Antonella Darbesio(JNC (Japan)), Mario Boccadoro(University of Turin)
Cited by 9
Related Papers
International Staging System for Multiple Myeloma
|Journal of Clinical Oncology|2005|2.9k
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
|Journal of Clinical Oncology|2015|2.2k